Silence Therapeutics PLC is developing a new generation of medicines by harnessing the body's natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with...
Danakali Ltd (ASX:DNK) is focused on the development of the Colluli Sulphate of Potash Project in Eritrea, East Africa. The company is evaluating renewable options of solar, wind and geothermal energy for becoming a zero-carbon company in the...
Join our audience of astute high net worth investors, fund managers, private client brokers and analysts
Look beyond the numbers and meet the people creating the value for shareholders
Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story
Watch the event afterwards on our YouTube channel